[go: up one dir, main page]

FR2597751B1 - SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES - Google Patents

SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES

Info

Publication number
FR2597751B1
FR2597751B1 FR8606222A FR8606222A FR2597751B1 FR 2597751 B1 FR2597751 B1 FR 2597751B1 FR 8606222 A FR8606222 A FR 8606222A FR 8606222 A FR8606222 A FR 8606222A FR 2597751 B1 FR2597751 B1 FR 2597751B1
Authority
FR
France
Prior art keywords
primeverosyl
genkwanine
senegenin
plant
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8606222A
Other languages
French (fr)
Other versions
FR2597751A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8606222A priority Critical patent/FR2597751B1/en
Publication of FR2597751A1 publication Critical patent/FR2597751A1/en
Application granted granted Critical
Publication of FR2597751B1 publication Critical patent/FR2597751B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8606222A 1986-04-24 1986-04-24 SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES Expired - Lifetime FR2597751B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8606222A FR2597751B1 (en) 1986-04-24 1986-04-24 SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8606222A FR2597751B1 (en) 1986-04-24 1986-04-24 SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES

Publications (2)

Publication Number Publication Date
FR2597751A1 FR2597751A1 (en) 1987-10-30
FR2597751B1 true FR2597751B1 (en) 1990-10-05

Family

ID=9334753

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8606222A Expired - Lifetime FR2597751B1 (en) 1986-04-24 1986-04-24 SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES

Country Status (1)

Country Link
FR (1) FR2597751B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867476B1 (en) * 2004-03-11 2006-05-26 Michel Prost GENKWANINE AND SAKURANETINE DERIVATIVES, COSMETIC AND THERAPEUTIC USE, AND PREPARATION METHOD
CN101456886B (en) * 2007-12-10 2013-04-10 上海国源生物技术有限公司 Use of daphne primeverose-genkwanin and daphne plant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2202683A1 (en) * 1972-10-13 1974-05-10 Tubery Pierre Trihydroxy oleanine dioil acid - antiinflammatory useful in treatment of sclerosis, psoriasis, eczemas and to prevent graft rejection
FR2510580A1 (en) * 1981-07-28 1983-02-04 Ragot Jacqueline NOVEL FLAVONIC HETEROSIDE EXTRACT FROM GNIDIA KRAUSSIANA, FOR USE IN MULTIPLE SCLEROSIS, AUTOIMMUNE CONDITIONS AND CERTAIN MALIGNANT PROLIFERATIONS
FR2510557A1 (en) * 1981-07-28 1983-02-04 Tubery Pierre Magnesium senegenate anti:allergic and anti:leukaemic agent - is prepd. by treating senegenine with magnesium carbonate

Also Published As

Publication number Publication date
FR2597751A1 (en) 1987-10-30

Similar Documents

Publication Publication Date Title
IT1225494B (en) APPARATUS TO PREVENT TRAINING AND TAKE CARE OF PADS IN LONG PATIENTS
GB2197647B (en) Improvements in or relating to water treatment devices
EP0275665A3 (en) Improvements in and relating to educational devices
EP0253094A3 (en) Use of prostaglandin d2-active substances in the treatment of ocular hypertension and glaucoma
ES509285A0 (en) "IMPROVEMENTS IN A DEVICE TO DO PHYSICAL EXERCISES TO DEVELOP AND CONDITION DIFFERENT PARTS OF THE HUMAN BODY".
LV10357A (en) A New Pharmaceutical Composition That is a Satisfaction of the Acquisition and Its Use in the Treatment of Lord and Intestinal Diseases
DE19675037I1 (en) Means to lower blood pressure
PT80384A (en) BIPOLAR PIEZOELECTRIC SPARK DISCHARGE ELECTRODES FOR THE RELIEF OF PAIN AND CONTRACTURE IN DIRECT APPLICATION TO SKIN CONTACT
FI864760L (en) Artificial gland to be implanted in the human body
FR2647675B1 (en) USE OF A STATINE DERIVATIVE IN THE TREATMENT OF EYE CONDITIONS
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
GB2107587B (en) Composition in the form of a shampoo based on anthralin or a derivative thereof and its use in the treatment of skin diseases
GB2223225B (en) Neutrophil-activating factor: its production and use in treatment
FR2597751B1 (en) SYNERGY EFFECT BETWEEN TWO PLANT-BASED MOLECULES: SENEGENIN AND 5-O-B-D-PRIMEVEROSYL GENKWANINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO IMMUNE IMBALANCES
GB2191949B (en) Improvements in and relating to medical instruments
FR2630910B1 (en) THERAPEUTIC TREATMENT TABLE
FR2619008B1 (en) USE OF SYNERGISTINS IN ANTI-ACNEIC PHARMACEUTICAL OR COSMETIC COMPOSITIONS
BR8802399A (en) DEVICE TO RECOVER AND REINJECT YOUR OWN BLOOD IN THE ORGANISM OF A PATIENT
FR2598082B1 (en) PROPHYLACTIC AND THERAPEUTIC AGENT FOR THE TREATMENT OF HEPATIC DISORDERS
JPS5631755A (en) Diagnosing device in acupuncture and moxibustion treatment
FR2515036B1 (en) COMPOSITION STABLE TO THE OXIDATION OF ANTHRALINE OR A DERIVATIVE THEREOF AND ITS USE IN THE TREATMENT OF SKIN DISEASES
GB8810950D0 (en) Improvements in/relating to treatment of textile materials
FR2597752B1 (en) SYNERGY EFFECT BETWEEN SENEGENIN AND POLYSACCHARIDE EXTRACTED FROM GNIDIA KRAUSSIANA IN THE TREATMENT OF CERTAIN ALLERGIES
FR2594690B1 (en) REGENERATING AND STIMULATING COMPOSITIONS OF THE DERMIS
CU21316A1 (en) Skin carrier to the use in mechanic dermo-expandor (meshgraft ii and mod-i) to the treatment and rehabilitation in patient with serious burns

Legal Events

Date Code Title Description
ST Notification of lapse